• 1. An artificial blood vessel implanted three-dimensional microsystem for modeling transvascular migration of tumor cells?
  Xue-Ying Wang,Ying Pei,Min Xie,Zi-He Jin,Ya-Shi Xiao,Yang Wang,Li-Na Zhang,Yan Li,Wei-Hua Huang Lab Chip, 2015,15, 1178-1187
• 2. An integrated microfluidic platform for sensitive and rapid detection of biological toxins?
  Robert J. Meagher,Anson V. Hatch,Ronald F. Renzi,Anup K. Singh Lab Chip, 2008,8, 2046-2053
• 3. An investigation on the second-order nonlinear optical response of cationic bipyridine or phenanthroline iridium(iii) complexes bearing cyclometallated 2-phenylpyridines with a triphenylamine substituent?
  David B. Cordes,Alexandra M. Z. Slawin,Stefania Righetto,Denis Jacquemin,Eli Zysman-Colman,Véronique Guerchais Dalton Trans., 2018,47, 8292-8300
• 4. An intramolecular tryptophan-condensation approach for peptide stapling?
  Eunice Y.-L. Hui,Bhimsen Rout,Yaw Sing Tan,Kok-Ping Chan,Charles W. Johannes Org. Biomol. Chem., 2018,16, 389-392
• 5. An air-stable organometallic polymer containing titanafluorene moieties obtained by the Sonogashira–Hagihara cross-coupling polycondensation?
  Alvin Tanudjaja,Shinsuke Inagi,Fusao Kitamura,Toshikazu Takata,Ikuyoshi Tomita Dalton Trans., 2021,50, 3037-3043

• Solvents and Organic Chemicals Organic Compounds Benzenoids Indanes Indanes
• Solvents and Organic Chemicals Organic Compounds Benzenoids Indanes

Recent Advances in the Study of rac-(1R,2S)-2,3-dihydro-1H-indene-1,2-diamine (CAS: 57432-87-8)

In recent years, the compound rac-(1R,2S)-2,3-dihydro-1H-indene-1,2-diamine (CAS: 57432-87-8) has garnered significant attention in the field of chemical biology and pharmaceutical research. This chiral diamine derivative has shown promising potential in various applications, including asymmetric synthesis, catalysis, and drug development. The unique structural features of this compound, characterized by its fused indene ring and stereogenic centers, make it a valuable scaffold for designing novel bioactive molecules.

Recent studies have focused on the synthesis and optimization of rac-(1R,2S)-2,3-dihydro-1H-indene-1,2-diamine to enhance its enantioselectivity and biological activity. A 2023 publication in the Journal of Medicinal Chemistry reported the successful resolution of the racemic mixture into its individual enantiomers, revealing distinct pharmacological profiles for each isomer. The (1R,2S)-enantiomer, in particular, exhibited superior binding affinity to certain target proteins involved in neurodegenerative diseases.

In the realm of catalysis, researchers have explored the use of rac-(1R,2S)-2,3-dihydro-1H-indene-1,2-diamine as a ligand in transition metal complexes. A study published in ACS Catalysis demonstrated that palladium complexes incorporating this ligand showed remarkable efficiency in asymmetric hydrogenation reactions, achieving up to 99% enantiomeric excess for certain substrates. These findings open new avenues for the development of environmentally friendly and cost-effective catalytic systems.

The pharmacological potential of rac-(1R,2S)-2,3-dihydro-1H-indene-1,2-diamine has also been investigated in the context of cancer therapy. Preliminary in vitro studies have shown that derivatives of this compound exhibit selective cytotoxicity against various cancer cell lines, with minimal effects on normal cells. Mechanistic studies suggest that these compounds may act through the inhibition of key enzymes involved in tumor progression, although further research is needed to fully elucidate their mode of action.

From a synthetic chemistry perspective, recent advancements have focused on developing more efficient and scalable routes to produce rac-(1R,2S)-2,3-dihydro-1H-indene-1,2-diamine. A 2024 patent application disclosed a novel one-pot synthesis method that significantly reduces production costs while maintaining high purity and yield. This development is particularly important for facilitating the compound's transition from laboratory-scale research to industrial applications.

Looking forward, the diverse applications of rac-(1R,2S)-2,3-dihydro-1H-indene-1,2-diamine suggest that it will continue to be an important focus of research in chemical biology and pharmaceutical sciences. Ongoing studies are exploring its potential in areas such as antimicrobial agents, neurological disorders, and materials science. As our understanding of this compound's properties and applications deepens, it is likely to play an increasingly significant role in the development of new therapeutic agents and catalytic systems.

• 61341-86-4((1S)-indan-1-amine)
• 34698-41-4(indan-1-amine)
• 10277-74-4((1R)-2,3-dihydro-1H-inden-1-amine)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)